Table 2.
Kaplan–Meier survival analysis
| Number | Mean DSS (months) | 95% CI (months) | p value | |
|---|---|---|---|---|
| All patients | ||||
| CD 59 − | 387 | 66 | 61–77 | |
| CD 59 + | 62 | 51 | 39–64 | 0.0231 |
| TNM stage 0–II only | ||||
| CD 59 − | 209 | 86 | 79–92 | |
| CD 59 + | 33 | 67 | 50–84 | |
| TNM stage III and IV only | ||||
| CD 59 − | 178 | 43 | 36–49 | |
| CD 59 + | 29 | 32 | 17–46 | 0.0173 |